- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03694366
Integrated Community Based Health Systems Strengthening in Northern Togo (ICBHSS-Togo)
Integrated Community Based Health Systems Strengthening in Northern Togo: A Stepped-Wedge Randomized Cluster Pragmatic Control Trial
Study Overview
Status
Intervention / Treatment
Detailed Description
Background: Over the past decade the burden of poor maternal and child health outcomes in Togo, particularly in the Northern regions, have remained high despite global progress. The principal causes of under-5 deaths in Togo are diseases with effective and low-cost prevention and or treatment strategies, including malaria (18%), acute lower respiratory infections (15%), and diarrheal diseases (8%).While Togo has an official plan for the integrated management of childhood illness (IMCI), including a permissive policy on integrated community case management (iCCM), challenges in implementation persist with low public sector health service utilization.There are critical gaps in access and quality of community health systems throughout the country and an urgent need to improve health outcomes through expanding access and quality of services.
Intervention: The investigators have adapted an integrated facility and community-based health systems strengthening (ICBHSS) model to improve primary healthcare services in Togo. The ICBHSS model includes a bundle of evidence based interventions including (1) community engagement meetings and feedback; (2) the elimination of facility user fees for children under five and pregnant women; (3) pro-active community based IMCI using Community Health Workers (CHWs) with additional services including linkage to family planning and counseling, HIV testing & referrals; (4) clinical mentoring and enhanced supervision at public sector facilities; and (5) improved supply chain management and facility structures. In 2015, a pilot ICBHSS initiative was launched in partnership with the Ministry of Health (MOH) at four public sector clinics in Northern Togo. Preliminary results from this pilot intervention suggested a meaningful reduction in children under-5 deaths, with a trend in reduction for under-one deaths as well as increased health service utilization at all 4 sites. In collaboration with MOH and technical partners, IH developed a plan to expand the ICBHSS model to 21 distinct health facilities over a four-year period in four additional districts: Bassar, Binah, Dankpen, and Kéran. The planned roll out includes expanding into a new district every 12 months based on budgetary and feasibility considerations. As part of this expansion planned for 2018, Integrate Health (IH) and MOH partners are planning an implementation study to both improve service delivery at expansion sites and inform national scale strategies.
Study: The investigators will conduct a mixed methods assessment, using the RE-AIM framework to evaluate the impact and implementation of the ICBHSS initiative in 4 districts. Consists of three key components: (1) a stepped-wedge randomized cluster pragmatic control trial to obtain annual coverage, effectiveness, and adoption metrics using a population-based household survey, (2) health facility assessments to be completed at the cluster (district) level for each health facility prior to intervention launch and post-intervention, and (3) key informant interviews conducted at 12, 24, 48 months for each cluster. The primary outcome will be under 5 year old mortality rate, with secondary outcomes including under-one mortality rate, maternal mortality rate, as well as maternal and child health service utilization.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Locations
-
-
-
Kara, Togo
- Recruiting
- Integrate Health
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Female of reproductive age (aged 15-49 years)
- Individuals aged 15-17 years will only be included if they have children and/or are pregnant
- Lives in selected household within study catchment area
- Informed consent is obtained for participants 18-49
- Waiver of parental permission is obtained for 15-17 year-old participants
Exclusion Criteria:
- None
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Five facilities in Bassar District
Estimated population of 34,676 served by five public sector facilities in Bassar District.
|
Bundle of evidence-based interventions that include the following 5 components:
|
|
Seven facilities in Binah District
Estimated population of 31,027 served by seven public sector facilities in Binah District.
|
Bundle of evidence-based interventions that include the following 5 components:
|
|
Four facilities in Dankpen District
Estimated total population of 40,165 served by four public sector facilities in Dankpen District.
|
Bundle of evidence-based interventions that include the following 5 components:
|
|
Five facilities in Kéran District
Estimated total population of 31,866 served by five public sector facilities in Kéran District.
|
Bundle of evidence-based interventions that include the following 5 components:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Under-five year old mortality rate
Time Frame: 48 months
|
The under-five mortality rate (expressed as a rate per 1,000 live births) is the probability of a child dying in a specified year between birth and 5 years of age.
|
48 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Under-one year old mortality rate
Time Frame: 48 months
|
The under-one mortality rate (expressed as a rate per 1,000 live births) is the probability of a child dying in a specified year between birth and 1 year of age.
|
48 months
|
|
Maternal mortality rate
Time Frame: 48 months
|
The maternal mortality rate (expressed as a rate per 100,000 live births) is the probability of a mother dying in a specified year within 42 days of pregnancy termination .
|
48 months
|
|
Proportion of children under age five reported to be febrile in the prior two weeks who received an effective antimalarial treatment within 24 hours of symptom onset.
Time Frame: 48 months
|
The number of febrile children under-five who received an effective antimalarial treatment within 24 hours of symptom onset out of the total number of children under age five reported to be febrile in the prior two weeks.
|
48 months
|
|
Proportion of children under age five reported to have a cough in the prior two weeks who received an effective pneumonia treatment within 24 hours of symptom onset.
Time Frame: 48 months
|
The number of children under-five who received an effective pneumonia treatment within 24 hours of symptom onset out of the total number of children under age five reported to have a cough in the prior two weeks.
|
48 months
|
|
Proportion of children under age five reported to have diarrhea in the prior two weeks who received an effective treatment for diarrheal disease within 24 hours of symptom onset.
Time Frame: 48 months
|
The number of children under-five who received an effective treatment for diarrheal disease within 24 hours of symptom onset out of the total number of children under age five reported to have diarrhea in the prior two weeks.
|
48 months
|
|
Maternal facility based birth delivery incidence rate
Time Frame: 48 months
|
The proportion of women reported to have delivered in a health facility.
|
48 months
|
|
Protocol Adherence by IH community health workers in iCCM and maternal consultations
Time Frame: 48 months
|
The average adherence by IH community health workers to evidence based protocols for iCCM and maternal consultations.
|
48 months
|
|
Protocol adherence by clinical staff at IH intervention facilities in iCCM and maternal consultations
Time Frame: 48 months
|
The average adherence by public sector clinical staff at IH intervention sites to evidence based protocols for iCCM and maternal consultations.
|
48 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Kevin P Fiori, Jr., MD, MPH, Integrate Health; Albert Einstein School of Medicine
Publications and helpful links
General Publications
- Fiori K, Schechter J, Dey M, Braganza S, Rhatigan J, Houndenou S, Gbeleou C, Palerbo E, Tchangani E, Lopez A, Bensen E, Hirschhorn LR. Closing the delivery gaps in pediatric HIV care in Togo, West Africa: using the care delivery value chain framework to direct quality improvement. AIDS Care. 2016 Mar;28 Suppl 2(sup2):29-33. doi: 10.1080/09540121.2016.1176678.
- McCarthy KJ, Braganza S, Fiori K, Gbeleou C, Kpakpo V, Lopez A, Schechter J, Singham Goodwin A, Jones HE. Identifying inequities in maternal and child health through risk stratification to inform health systems strengthening in Northern Togo. PLoS One. 2017 Mar 16;12(3):e0173445. doi: 10.1371/journal.pone.0173445. eCollection 2017.
- Lauria ME, Fiori KP, Jones HE, Gbeleou S, Kenkou K, Agoro S, Agbere AD, Lue KD, Hirschhorn LR. Assessing the Integrated Community-Based Health Systems Strengthening initiative in northern Togo: a pragmatic effectiveness-implementation study protocol. Implement Sci. 2019 Oct 16;14(1):92. doi: 10.1186/s13012-019-0921-3.
Helpful Links
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- ICBHSS
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Maternal and Child Health
-
Bahir Dar UniversityNot yet recruitingMaternal and Child Health | Maternal NutritionEthiopia
-
Mbarara University of Science and TechnologyMassachusetts General Hospital; University of Alabama at BirminghamCompletedMaternal Child HealthUganda
-
IRCCS Burlo GarofoloRecruiting
-
Gadjah Mada UniversityNot yet recruitingMaternal and Child Health
-
National University of SingaporeSaglik Bilimleri UniversitesiRecruitingMaternal and Child HealthCambodia
-
University of California, DavisUniversity of Michigan; University of California, Riverside; Lahore University...TerminatedMaternal and Child HealthPakistan
-
Healthy Child UgandaCompleted
-
Onyango SangoroUniversity College, London; Safe Water and Aids Project, Kenya; NaiLab, Kenya; Safaricom...UnknownMaternal and Child HealthKenya
-
Karnataka Health Promotion TrustUniversity of Manitoba; Bill and Melinda Gates FoundationCompleted
-
Vanderbilt UniversityCompletedMidwifery | Prenatal Care | Maternal Health Services | Perinatal Care | Maternal-child Health ServicesUnited States
Clinical Trials on ICBHSS model
-
Integrate HealthAlbert Einstein College of Medicine; Montefiore Medical Center; City University... and other collaboratorsUnknownMaternal-Child Health Services | Health Service UtilizationTogo
-
Johnson & Johnson Surgical Vision, Inc.TerminatedCataractUnited States
-
National University, SingaporeUnknown
-
Medtronic Cardiac SurgeryCompleted
-
Sun Yat-sen UniversityQueen's University, Belfast; Orbis; Aravind Eye Care System; Padmashree Dr. D.... and other collaboratorsCompleted
-
University of ParmaCompletedMotor Activity | Hemiplegic Cerebral PalsyItaly
-
Johnson & Johnson Surgical Vision, Inc.Completed
-
University of PittsburghPatient-Centered Outcomes Research InstituteCompletedHearing Loss, Age-RelatedUnited States
-
CORD, LLCTerminated
-
Osmaniye Korkut Ata UniversityCompleted